LBTSF (Almirall) Total Operating Expense: $1,007 Mil (TTM As of Mar. 2026)


LBTSF Almirall SA LBTSF
85 GF Score
Price $15.35
GF Value $16.87
! 4 Warning Signs
View Full Analysis

What is Almirall Total Operating Expense?

Almirall LBTSF 85 Total Operating Expense is $1,007 Mil as of Mar. 2026. GuruFocus rates LBTSF with a GF Score™ of 85/100 and a GF Value™ of $16.87. The stock has 4 warning signs investors should review.

Almirall's Total Operating Expense for the three months ended in Mar. 2026 was $183 Mil. Almirall's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $1,007 Mil.

Almirall Total Operating Expense Related Terms

Almirall Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Almirall's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Total Operating Expense Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 614.98 628.92 698.81 754.88 942.46

Almirall Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 170.49 277.85 78.53 467.96 182.78
LBTSF
85GF Score
Almirall SA LBTSF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almirall Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,007 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1,007 Mil mean?
Almirall (LBTSF) has a Total Operating Expense of $1,007 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Almirall and its competitors.
Is Almirall's Total Operating Expense too high?
Almirall's current Total Operating Expense is $1,007 Mil. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Total Operating Expense compare to ZTS and UTHR?
Almirall's Total Operating Expense of $1,007 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Almirall and its competitors. Almirall's current Total Operating Expense is $1,007 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Total Operating Expense of $1,007 Mil. The stock's GF Value™ is $16.87, compared to a current price of $15.35 — trading 9% below its estimated fair value. The current Total Operating Expense is $1,007 Mil. Almirall's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Almirall (LBTSF), the current Total Operating Expense is $1,007 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 9% below its estimated GF Value™ of $16.87.

Key valuation signals for LBTSF:

  • Total Operating Expense: $1,007 Mil
  • GF Value™: $16.87 vs. price of $15.35 (9% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
85GF Score

Get the complete analysis for LBTSF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$16.87
GF Value